Article: A case study of bioengineering in America: profits, risks and standards of value in the commercialization of Monsanto Company|s newleaf potato Journal: Interdisciplinary Environmental Review (IER) 1999 Vol.1 No.2 pp.129 - 143 Abstract: Last year, approximately 45 million acres of American farmland were planted with crops that had been genetically engineered to either produce their own pesticides, or withstand herbicides. The long and short-term effects of this biotechnology on humans and the environment, are being studied, but remain unknown. Leading the way in the field of bioengineered crops is the Missouri-based Monsanto Company. Monsanto believes that current agricultural practices are inconsistent with sustainable development. The NewLeaf potato is one of three products Monsanto has created to feed the growing world population. The genetically engineered crop produces, in every cell of the plant, a pesticide that kills its most common predators. This paper offers a case study of the development, regulation, and commercialisation of Monsanto|s bioengineered potato. It is an interdisciplinary approach that focuses on the economic, environmental, and the ethical facets of how the product was created, and how it has been brought to market. The paper will bring to light the inherent benefits, risks, and the standards of value used in assessing this contemporary implementation of biotechnology. Inderscience Publishers - linking academia, business and industry through research

Title: A case study of bioengineering in America: profits, risks and standards of value in the commercialization of Monsanto Company's newleaf potato

Authors: Bridget Lyons, Teresa Ralabate, Nadhim Frangul

Addresses: Sacred Heart University, USA. ' USA. ' Sacred Heart University, USA

Abstract: Last year, approximately 45 million acres of American farmland were planted with crops that had been genetically engineered to either produce their own pesticides, or withstand herbicides. The long and short-term effects of this biotechnology on humans and the environment, are being studied, but remain unknown. Leading the way in the field of bioengineered crops is the Missouri-based Monsanto Company. Monsanto believes that current agricultural practices are inconsistent with sustainable development. The NewLeaf potato is one of three products Monsanto has created to feed the growing world population. The genetically engineered crop produces, in every cell of the plant, a pesticide that kills its most common predators. This paper offers a case study of the development, regulation, and commercialisation of Monsanto|s bioengineered potato. It is an interdisciplinary approach that focuses on the economic, environmental, and the ethical facets of how the product was created, and how it has been brought to market. The paper will bring to light the inherent benefits, risks, and the standards of value used in assessing this contemporary implementation of biotechnology.

Keywords: bioengineering; USA; United States; company profits; risks; standards; commercialisation; Monsanto; newleaf potato; genetically modified crops; GM crops; genetic engineering; biotechnology; sustainable development; sustainability; bioengineered potatoes; GM potatoes; interdisciplinary approach; economics; environmental impact; ethics.

DOI: 10.1504/IER.1999.053848

Interdisciplinary Environmental Review, 1999 Vol.1 No.2, pp.129 - 143

Published online: 13 May 2013 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article

Title: A case study of bioengineering in America: profits, risks and standards of value in the commercialization of Monsanto Company's newleaf potato

Keep up-to-date